Shanghai Rongtai Health Technology Corporation Limited

SSE:603579.SS

27.02 (CNY) • At close May 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42014 Q22014 Q1
Revenue 394.971432.552335.1421.48400.614556.955408.173504.183385.719442.584460.878536.561564.797747.545616.648728.058520.32615.273526.44552.571326.233684.814531.986585.983511.128537.745521.908633.087602.908640.655455.606456.177365.569431.317262.152310.988280.593338.201160.825160.825
Cost of Revenue 266.434304.265235.418300.478256.891398.644273.699338.113272.786323.019334.993405.237409.821552.49464.122530.904363.95490.596354.267370.924224.787440.414375.314411.872362.627341.871358.856422.058390.819403.001283.132278.129220.713262.817161.605197.374172.903217.281113.391113.391
Gross Profit 128.537128.28799.682121.002143.723158.311134.475166.07112.933119.565125.885131.324154.977195.056152.525197.154156.37124.677172.173181.647101.447244.4156.673174.112148.501195.874163.052211.029212.089237.654172.474178.048144.856168.5100.547113.614107.69120.92147.43447.434
Gross Profit Ratio 0.3250.2970.2970.2870.3590.2840.3290.3290.2930.270.2730.2450.2740.2610.2470.2710.3010.2030.3270.3290.3110.3570.2950.2970.2910.3640.3120.3330.3520.3710.3790.390.3960.3910.3840.3650.3840.3580.2950.295
Reseach & Development Expenses 21.31123.09618.88517.05120.14220.75222.15720.03417.23418.65524.33220.50525.16730.53630.35531.98426.33227.81228.15221.7222.43734.06533.51737.2417.7824.96825.70926.82631.254101.132038.391060.463027.931047.1998.2568.256
General & Administrative Expenses 19.462-31.80647.578-10.57820.521-36.6549.413-9.79516.749-57.80754.779-1.51321.81-29.84344.014-9.87916.935-29.54513.694-6.89314.565-53.24921.247-8.6321.999-122.49848.635-32.56851.307-79.24540.092-10.84524.267-55.44123.743-14.69620.337-45.73615.315.3
Selling & Marketing Expenses 42.2925.32665.87750.83139.27752.90345.59963.32742.61563.14947.88252.1946.41197.19351.80769.13237.17925.76154.54364.22544.44789.49454.11664.7157.94683.15862.00275.40562.91992.81765.38358.97946.20973.54933.8838.90528.24240.32915.22615.226
SG&A 61.755-26.479113.45569.48759.79816.25295.01253.53259.3645.342102.66150.67768.22167.3595.82159.25354.114-3.78568.23757.33259.01236.24575.36356.07979.946-39.341110.63842.837114.22613.572105.47548.13470.47618.10857.62324.20948.579-5.40731.12531.125
Other Expenses -7.77779.109-1.002-0.1110.01-15.4636.829-4.786-3.24351.276-29.30825.379-2.2353.5950.161-2.3120.077-0.433-0.8-1.921-0.36415.1790.64713.0941.301-7.6750.284-3.7781.053-10.9782.108-0.7340.5976.181.0252.9720.653.50300
Operating Expenses 75.28875.72668.14986.64981.42691.65488.402102.65173.35475.27497.68696.56191.158151.48193.094112.06980.15865.43296.51399.04875.493116.846104.709112.73195.684123.957104.348126.143114.437151.28106.091103.67171.186107.24857.96763.07748.9863.98232.64632.646
Operating Income 53.24952.56128.99634.35469.25467.17449.61975.80343.35934.17544.6839.87667.80557.72552.70980.90873.88429.9165.50672.91932.02795.00779.89490.98961.02469.77347.10992.28271.52270.43852.8864.26169.9474.48644.14756.3657.92761.4816.25216.252
Operating Income Ratio 0.1350.1220.0870.0820.1730.1210.1220.150.1120.0770.0970.0740.120.0770.0850.1110.1420.0490.1240.1320.0980.1390.150.1550.1190.130.090.1460.1190.110.1160.1410.1910.1730.1680.1810.2060.1820.1010.101
Total Other Income Expenses Net -0.268-0.1516.83518.1350.01-8.0042.598-0.5550.1980.972-0.266-7.839-0.038-2.186-0.89-3.670.077-0.533-0.8-0.493-0.364-0.3180.647-0.7551.301-1.0990.2840.941.053-2.0042.3381.2630.5275.6471.012.3330.6263.5830.1440.144
Income Before Tax 52.98152.4135.83148.2969.26459.1752.21675.24843.55735.14744.61531.84367.76755.53951.81979.64673.9629.37764.70672.42531.66494.68980.54290.23462.32468.67547.39393.22172.57668.43454.9865.70270.52680.13345.15758.69358.55365.06315.31315.313
Income Before Tax Ratio 0.1340.1210.1070.1150.1730.1060.1280.1490.1130.0790.0970.0590.120.0740.0840.1090.1420.0480.1230.1310.0970.1380.1510.1540.1220.1280.0910.1470.120.1070.1210.1440.1930.1860.1720.1890.2090.1920.0950.095
Income Tax Expense 8.9823.3944.4133.9626.4168.3165.0927.575.882-3.3695.1943.6249.20412.297.0048.7164.921-1.0566.6137.6214.02713.7728.7729.0078.0738.8552.7639.88910.4195.7477.4797.0112.81712.2835.4057.3688.4748.6392.5022.502
Net Income 43.93949.43431.17548.59562.74250.97346.81667.41737.50138.56139.29928.04158.32647.73948.2371.73568.63233.35460.5669.48129.60686.64171.99679.18457.76865.41842.46783.07158.25461.16743.75356.35254.90466.72639.47450.85949.58755.92212.63412.634
Net Income Ratio 0.1110.1140.0930.1150.1570.0920.1150.1340.0970.0870.0850.0520.1030.0640.0780.0990.1320.0540.1150.1260.0910.1270.1350.1350.1130.1220.0810.1310.0970.0950.0960.1240.150.1550.1510.1640.1770.1650.0790.079
EPS 0.250.2840.180.280.470.380.350.50.280.280.290.210.440.330.350.520.50.240.430.520.220.640.510.560.410.460.30.60.420.450.310.440.430.640.380.480.470.530.130.13
EPS Diluted 0.240.260.160.250.420.350.350.490.280.280.280.20.420.310.350.520.480.240.430.520.220.640.510.560.410.460.30.60.420.450.310.440.430.640.380.480.470.530.130.13
EBITDA 60.34154.72131.0464.54684.51477.02173.395103.75671.46562.59266.48757.10894.99965.45168.691101.20298.5233.87476.90483.67548.991121.35182.798117.17585.18351.99185.50478.59897.65252.53870.28167.12973.7493.61942.5864.1458.70977.03618.47318.473
EBITDA Ratio 0.1530.1270.0930.1530.2110.1380.180.2060.1850.1410.1440.1060.1680.0880.1110.1390.1890.0550.1460.1510.150.1770.1560.20.1670.0970.1640.1240.1620.0820.1540.1470.2020.2170.1620.2060.2090.2280.1150.115